IDEX Biometrics - Approved Prospectus - 13 Nov 2024

13 Nov 2024 18:00 CET

Reference is made to the stock exchange announcement issued by IDEX Biometrics
ASA (the "Company") on 17 September 2024 regarding the successful private
placement of 466,666,666 new shares ("Private Placement" and the "Private
Placement Shares"), and the possible subsequent offering of up to 140,000,000
new shares ("Subsequent Offering" and the "Subsequent Offering Shares").

As stated in the announcement on 17 September 2024, the listing of the Private
Placement Shares and the offering and listing of the Subsequent Offering Shares
remained subject to approval of a prospectus ("Prospectus") by the Financial
Supervisory Authority of Norway ("FSA"), and the subsequent publication of such
Prospectus by the Company. Further, the admission to trading of warrants issued
to participants in the Private Placement and the Subsequent Offering, as well as
the listing of certain shares issued in the private placement resolved on 20
August 2024, remained subject to the approval and publication of the Prospectus.

The FSA has today approved the Prospectus.

As a result of the above, the subscription period for the Subsequent Offering
starts on 15 November 2024 and expires on 29 November 2024 at 16:30 CET. For
further information on the Subsequent Offering, please refer to the Prospectus.

The Prospectus is enclosed with this notice. It will also be available in
electronic format at https://www.idexbiometrics.com/investors/share-
information/prospectuses/ (https://www.idexbiometrics.com/investors/share-
%20information/prospectuses/). Printed copies of the Prospectus may be obtained
free of charge at the office of IDEX Biometrics ASA, Dronning Eufemias gate 16,
NO- 0191 Oslo, Norway, telephone +47 6783 9119 or by e-mail:
companysecretary@idexbiometrics.com
(mailto:companysecretary@idexbiometrics.com).

Arctic Securities AS acted as financial advisor and bookrunner in connection
with the Private Placement and the Subsequent Offering (the "Manager"). Ræder
Bing advokatfirma AS acted as the Company's legal advisor. Advokatfirmaet
Thommessen AS acted as legal advisor to the Manager.

Contact persons:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)
Tel: +47 6783 9119

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com)

About this notice:
This notice was issued by Erling Svela, Vice President of Finance, on 13
November 2024 at 18:00 CET on behalf of IDEX Biometrics ASA. The information
shall be disclosed according to section 5-8 of the Norwegian Securities Trading
Act (STA) and released in accordance with section 5-12 of the STA.

More information:
Access the news on Oslo Bors NewsWeb site

632116_2024-11-13 Prospectus w subscr form - Pub.pdf